{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:09:11Z","timestamp":1792613351546,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Drug Delivery Science and Technology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jddst.2022.103921","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T19:04:15Z","timestamp":1666983855000},"page":"103921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19"],"prefix":"10.1016","volume":"77","author":[{"given":"Sally","family":"Abou Taleb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassmin","family":"Moatasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"GabAllah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1922-1554","authenticated-orcid":false,"given":"Marwa Hasanein","family":"Asfour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jddst.2022.103921_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.jddst.2022.103921_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6054-x","article-title":"Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer","volume":"19","author":"Islam","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jddst.2022.103921_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-319-24223-1_10","article-title":"Chemotherapy resistance in lung cancer","volume":"893","author":"Kim","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"Suppl 1","key":"10.1016\/j.jddst.2022.103921_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/01635581.2013.785004","article-title":"Chemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancer","volume":"65","author":"Mateen","year":"2013","journal-title":"Nutr. Cancer"},{"issue":"6","key":"10.1016\/j.jddst.2022.103921_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.arcmed.2014.08.002","article-title":"Molecular mechanisms of quercitrin-induced apoptosis in non-small cell lung cancer","volume":"45","author":"Cincin","year":"2014","journal-title":"Arch. Med. Res."},{"issue":"7798","key":"10.1016\/j.jddst.2022.103921_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jddst.2022.103921_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jddst.2022.103921_bib8","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3389\/fimmu.2020.01451","article-title":"Quercetin and vitamin C: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19)","volume":"11","author":"Colunga Biancatelli","year":"2020","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.jddst.2022.103921_bib9","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1021\/jf8006568","article-title":"Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity","volume":"56","author":"Benavente-Garcia","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jddst.2022.103921_bib10","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1017\/jns.2016.41","article-title":"Flavonoids: an overview","volume":"5","author":"Panche","year":"2016","journal-title":"J. Nutr. Sci."},{"issue":"4","key":"10.1016\/j.jddst.2022.103921_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3742\/OPEM.2006.6.4.355","article-title":"Antioxidant, antinociceptive activity and general toxicity study of Dendrophthoe falcata and isolation of quercitrin as the major component","volume":"6","author":"Hasan","year":"2006","journal-title":"Orient. Pharm. Exp. Med."},{"issue":"3","key":"10.1016\/j.jddst.2022.103921_bib12","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.31788\/RJC.2019.1235353","article-title":"Isolation of quercitrin from dendrophthoe pentandra (L.) Miq leaves and its antioxidant and antibacterial activities","volume":"12","author":"Hardiyanti","year":"2019","journal-title":"Rasayan J. Chem."},{"issue":"3\u20134","key":"10.1016\/j.jddst.2022.103921_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejps.2009.03.002","article-title":"Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication","volume":"37","author":"Choi","year":"2009","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.jddst.2022.103921_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43088-021-00107-w","article-title":"Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2","volume":"10","author":"Saakre","year":"2021","journal-title":"Beni-Suef Univ. J. Basic. Appl. Sci."},{"key":"10.1016\/j.jddst.2022.103921_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jare.2017.10.003","article-title":"Formulation and evaluation of pH-sensitive rutin nanospheres against colon carcinoma using HCT-116 cell line","volume":"9","author":"Asfour","year":"2018","journal-title":"J. Adv. Res."},{"issue":"9","key":"10.1016\/j.jddst.2022.103921_bib16","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.xphs.2021.05.007","article-title":"Fabrication of all-trans retinoic acid loaded chitosan\/tripolyphosphate lipid hybrid nanoparticles as a novel oral delivery approach for management of diabetic nephropathy in rats","volume":"110","author":"Asfour","year":"2021","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.jddst.2022.103921_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jddst.2018.03.004","article-title":"Cross-linked, cyclodextrin-based nanosponges for curcumin delivery-Physicochemical characterization, drug release, stability and cytotoxicity","volume":"45","author":"Pushpalatha","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.jddst.2022.103921_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s13346-020-00778-5","article-title":"Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies","volume":"11","author":"Santos","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"issue":"5","key":"10.1016\/j.jddst.2022.103921_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ddr.21452","article-title":"Cyclodextrin complexes: perspective from drug delivery and formulation","volume":"79","author":"Jacob","year":"2018","journal-title":"Drug Dev. Res."},{"issue":"3","key":"10.1016\/j.jddst.2022.103921_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/17425247.2016.1215301","article-title":"Tuning structural parameters for the optimization of drug delivery performance of cyclodextrin-based nanosponges","volume":"14","author":"Venuti","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jddst.2022.103921_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.859406","article-title":"Cyclodextrin-based nanosponges: overview and opportunities","volume":"10","author":"Utzeri","year":"2022","journal-title":"Front. Chem."},{"issue":"9","key":"10.1016\/j.jddst.2022.103921_bib22","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3109\/03639045.2012.694610","article-title":"Nanosponges - a completely new nano-horizon: pharmaceutical applications and recent advances","volume":"39","author":"Ahmed","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jddst.2022.103921_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10847-020-01003-z","article-title":"Fabrication and characterisation studies of cyclodextrin-based nanosponges for sulfamethoxazole delivery","volume":"97","author":"Ya\u015fayan","year":"2020","journal-title":"J. Inclusion Phenom. Macrocycl. Chem."},{"issue":"2","key":"10.1016\/j.jddst.2022.103921_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejpb.2009.11.003","article-title":"Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity","volume":"74","author":"Swaminathan","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.jddst.2022.103921_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10847-012-0192-y","article-title":"Structural evidence of differential forms of nanosponges of beta-cyclodextrin and its effect on solubilization of a model drug","volume":"76","author":"Swaminathan","year":"2013","journal-title":"J. Inclusion Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.jddst.2022.103921_bib26","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.2147\/IJN.S206350","article-title":"Improving the solubility and in vitro cytotoxicity (anticancer activity) of ferulic acid by loading it into cyclodextrin nanosponges","volume":"14","author":"Rezaei","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.jddst.2022.103921_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010162","article-title":"Improvement in the anti-tumor efficacy of doxorubicin nanosponges in in vitro and in mice bearing breast tumor models","volume":"12","author":"Argenziano","year":"2020","journal-title":"Cancers"},{"issue":"1\u20134","key":"10.1016\/j.jddst.2022.103921_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10847-011-0101-9","article-title":"In vitro enhancement of anticancer activity of paclitaxel by a Cremophor free cyclodextrin-based nanosponge formulation","volume":"74","author":"Mognetti","year":"2012","journal-title":"J. Inclusion Phenom. Macrocycl. Chem."},{"issue":"6","key":"10.1016\/j.jddst.2022.103921_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.22159\/ijap.2020v12i6.39430","article-title":"Lornoxicam-loaded nanosponges for controlled anti-inflammatory effect: in vitro\/in vivo assessment","volume":"12","author":"Shawky","year":"2020","journal-title":"Int. J. Appl. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.jddst.2022.103921_bib30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijpharm.2012.12.031","article-title":"Encapsulation of acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy","volume":"443","author":"Lembo","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.jddst.2022.103921_bib31","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1080\/03639045.2017.1371732","article-title":"Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation","volume":"43","author":"Zainuddin","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jddst.2022.103921_bib32","series-title":"Biomedical Innovations To Combat COVID-19, S. Rosales-Mendoza","first-page":"307","article-title":"Chapter 17 - the potential of drug delivery nanosystems to treat COVID-19","author":"Garc\u00eda-Silva","year":"2022"},{"key":"10.1016\/j.jddst.2022.103921_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.sajb.2021.05.021","article-title":"Bioactive compounds from Euphorbia schimperiana with cytotoxic and antibacterial activities","volume":"141","author":"Aljubiri","year":"2021","journal-title":"South Afr. J. Bot."},{"issue":"22","key":"10.1016\/j.jddst.2022.103921_bib34","doi-asserted-by":"crossref","first-page":"e00489","DOI":"10.1128\/MRA.00489-20","article-title":"Coding-complete genome sequences of two SARS-CoV-2 isolates from Egypt","volume":"9","author":"Kandeil","year":"2020","journal-title":"Microbiol. Resour. Announc."},{"issue":"3","key":"10.1016\/j.jddst.2022.103921_bib35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ddr.21632","article-title":"Investigation of a new horizon antifungal activity with enhancing the antimicrobial efficacy of ciprofloxacin and its binary mixture via their encapsulation in nanoassemblies: in vitro and in vivo evaluation","volume":"81","author":"Abou Taleb","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jddst.2022.103921_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111605","article-title":"Topical delivery of clobetasol propionate loaded nanosponge hydrogel for effective treatment of psoriasis: formulation, physicochemical characterization, antipsoriatic potential and biochemical estimation","volume":"119","author":"Kumar","year":"2021","journal-title":"Mater. Sci. Eng. C Mater Biol. Appl."},{"issue":"3","key":"10.1016\/j.jddst.2022.103921_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jsps.2020.01.016","article-title":"Formulation and evaluation of cyclodextrin-based nanosponges of griseofulvin as pediatric oral liquid dosage form for enhancing bioavailability and masking bitter taste","volume":"28","author":"Omar","year":"2020","journal-title":"Saudi Pharmaceut. J."},{"issue":"3\u20134","key":"10.1016\/j.jddst.2022.103921_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10847-012-0186-9","article-title":"Cyclodextrin-based nanosponges of curcumin: formulation and physicochemical characterization","volume":"75","author":"Darandale","year":"2013","journal-title":"J. Inclusion Phenom. Macrocycl. Chem."},{"issue":"1","key":"10.1016\/j.jddst.2022.103921_bib39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1208\/s12249-011-9584-3","article-title":"Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study","volume":"12","author":"Ansari","year":"2011","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"10.1016\/j.jddst.2022.103921_bib40","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1080\/03639045.2017.1361968","article-title":"Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes","volume":"43","author":"Mohsen","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.jddst.2022.103921_bib41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.2042-7158.1975.tb09378.x","article-title":"The concept of dissolution efficiency","volume":"27","author":"Khan","year":"1975","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.jddst.2022.103921_bib42","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.jddst.2022.103921_bib43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0022-1759(94)90034-5","article-title":"A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia","volume":"174","author":"van de Loosdrecht","year":"1994","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.jddst.2022.103921_bib44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/21691401.2018.1543198","article-title":"Stimuli-responsive polyvinylpyrrolidone-NIPPAm-lysine graphene oxide nano-hybrid as an anticancer drug delivery on MCF7 cell line","volume":"47","author":"Ashjaran","year":"2019","journal-title":"Artif. Cell Nanomed. Biotechnol."},{"issue":"12","key":"10.1016\/j.jddst.2022.103921_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ph13120443","article-title":"FDA-approved drugs with potent in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2","volume":"13","author":"Mostafa","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.jddst.2022.103921_bib46","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot087379","article-title":"Crystal violet assay for determining viability of cultured cells","author":"Feoktistova","year":"2016","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.jddst.2022.103921_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105117","article-title":"New quinoline-triazole conjugates: synthesis, and antiviral properties against SARS-CoV-2","volume":"114","author":"Seliem","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.jddst.2022.103921_bib48","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3762\/bjoc.8.235","article-title":"Cyclodextrin-based nanosponges as drug carriers","volume":"8","author":"Trotta","year":"2012","journal-title":"Beilstein J. Org. Chem."},{"issue":"2","key":"10.1016\/j.jddst.2022.103921_bib49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40199-020-00352-x","article-title":"Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis","volume":"28","author":"Iriventi","year":"2020","journal-title":"Daru"},{"issue":"6","key":"10.1016\/j.jddst.2022.103921_bib50","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/10837450.2019.1584633","article-title":"Transdermal fennel essential oil nanoemulsions with promising hepatic dysfunction healing effect: in vitro and in vivo study","volume":"24","author":"Mostafa","year":"2019","journal-title":"Pharmaceut. Dev. Technol."},{"issue":"8","key":"10.1016\/j.jddst.2022.103921_bib51","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1080\/03639045.2018.1442844","article-title":"In vitro and in vivo evaluation of cyclodextrin-based nanosponges for enhancing oral bioavailability of atorvastatin calcium","volume":"44","author":"Zidan","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"3","key":"10.1016\/j.jddst.2022.103921_bib52","first-page":"1045","article-title":"Solubility and dissolution rate enhancement of ibuprofen by cyclodextrin based carbonate nanosponges","volume":"34","author":"Shoaib","year":"2021","journal-title":"Pak. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.jddst.2022.103921_bib53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/pharmacy8040203","article-title":"Enhancing the solubility of curcumin using a solid dispersion system with hydroxypropyl-\u03b2-cyclodextrin prepared by grinding, freeze-drying, and common solvent evaporation methods","volume":"8","author":"Mai","year":"2020","journal-title":"Pharmacy"},{"issue":"2","key":"10.1016\/j.jddst.2022.103921_bib54","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1208\/s12249-009-9249-7","article-title":"Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes","volume":"10","author":"Patel","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jddst.2022.103921_bib55","article-title":"Novel \u03b2-cyclodextrin nanosponges by chain growth condensation for solubility enhancement of dexibuprofen: characterization and acute oral toxicity studies","volume":"61","author":"Khalid","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jddst.2022.103921_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejps.2016.12.005","article-title":"Phospholipid complex enriched micelles: a novel drug delivery approach for promoting the antidiabetic effect of repaglinide","volume":"99","author":"Kassem","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.jddst.2022.103921_bib57","first-page":"55","article-title":"Synthesis and characterization of furosemide complex in \u03b2-cyclodextrin","volume":"1","author":"Farcas","year":"2006","journal-title":"Dig J. Nanomater Biostruct."},{"key":"10.1016\/j.jddst.2022.103921_bib58","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ultsonch.2019.04.001","article-title":"Ultrasound processed cuminaldehyde\/2-hydroxypropyl-beta-cyclodextrin inclusion complex: preparation, characterization and antibacterial activity","volume":"56","author":"Cui","year":"2019","journal-title":"Ultrason. Sonochem."},{"issue":"2","key":"10.1016\/j.jddst.2022.103921_bib59","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ejpb.2009.11.011","article-title":"Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide","volume":"74","author":"Elgindy","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"11","key":"10.1016\/j.jddst.2022.103921_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141946","article-title":"2-Hydroxypropyl-beta-Cyclodextrin acts as a novel anticancer agent","volume":"10","author":"Yokoo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jddst.2022.103921_bib61","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.2147\/IJN.S315705","article-title":"Antiviral drug delivery system for enhanced bioactivity, better metabolism and pharmacokinetic characteristics","volume":"16","author":"Chen","year":"2021","journal-title":"Int. J. Nanomed."}],"updated-by":[{"DOI":"10.1016\/j.jddst.2023.104576","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000}}],"container-title":["Journal of Drug Delivery Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1773224722008322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1773224722008322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T04:45:11Z","timestamp":1761713111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1773224722008322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":61,"alternative-id":["S1773224722008322"],"URL":"https:\/\/doi.org\/10.1016\/j.jddst.2022.103921","relation":{},"ISSN":["1773-2247"],"issn-type":[{"value":"1773-2247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19","name":"articletitle","label":"Article Title"},{"value":"Journal of Drug Delivery Science and Technology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jddst.2022.103921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103921"}}